Treatment options for neonatal infections in the post-cefotaxime era

References

• Ku LC, Boggess KA, and Cohen-Wolkowiez M. Bacterial meningitis in infants. Clin Perinatol. 2015;42(1):29–45.
   PubMed Web of Science ®Google Scholar
• Korang SK, Safi S, Nava C, et al. Antibiotic regimens for early-onset neonatal sepsis. Cochrane Database Syst Rev. 2021;5:1–54.
   Google Scholar
• Odio CM. Cefotaxime for treatment of neonatal sepsis and meningitis. Diagn Microbiol Infect Dis. 1995;22(1–2):111–117.
   PubMed Web of Science ®Google Scholar
• Molyneux EM, Dube Q, Banda FM, et al. The treatment of possible severe infection in infants. Pediatr Infect Dis J. 2017;36(12):e328–e333.
   PubMed Web of Science ®Google Scholar
• Hyun MH. Pediatric acute kidney injury: focusing on diagnosis and management. Child Kidney Dis. 2020;24(1):19–26
   Google Scholar
• Bradley JS. Alternatives to consider during cefotaxime shortage. AAP News [Internet]; 2015 Feb 25 [cited 2021 Mar 28]. Available from: http://www.aappublications.org/content/early/2015/02/25/aapnews.20150225-1
   Google Scholar
• Gundlapalli AV, Beekmann SE, Graham DR, et al. Antimicrobial agent shortages: the new norm for infectious diseases physicians. Open Forum Infect Dis. 2018;5(4):ofy068.
   PubMed Web of Science ®Google Scholar
• Schaad UB, Wedgwood-Krucko J, Tschaeppeler H. Reversible ceftriaxone-associated biliary pseudolithiasis in children. Lancet. 1988;2(8625):1411–1413.
   PubMed Web of Science ®Google Scholar
• Arnold CJ, Ericson J, Cho N, et al., Cefepime and ceftazidime safety in hospitalized infants. Pediatr Infect Dis J. 2015;34(9):964–968.
   PubMed Web of Science ®Google Scholar
• Snelling S, Hart CA, Cooke RWI. Ceftazidime or gentamicin plus benzylpenicillin in neonates less than forty-eight hours old. J Antimicrob Chemother. 1983;12(suppl A):353–356.
   PubMedGoogle Scholar
• Low DC, Bissenden JG, Wise R. Ceftazidime in neonatal infections. Arch Dis Child. 1985;60(4):360–364.
   PubMed Web of Science ®Google Scholar
• Pacifici GM. Pharmacokinetics of cephalosporins in the neonate: a review.Clinics (Sao Paulo) 2011;66(7):1267–1274.
   PubMed Web of Science ®Google Scholar
• Miller JL, Johnson PN, White BP, et al. Impact of ceftazidime use on susceptibility patterns in the neonatal intensive care unit. Pediatr Infect Dis J. 2019;38(6):605–607.
   PubMed Web of Science ®Google Scholar
• Patel PD, Bhagat P, Bartlett AH, et al., Neonatal outcomes with cefotaxime versus ceftazidime. J Pediatr Pharmacol Ther. 2020;25(2):117–123.
   PubMedGoogle Scholar
• Sáez-Llorens X, O’Ryan M. Cefepime in the empiric treatment of meningitis in children. Pediatr Infect Dis J. 2001;20(3):356–361.
   PubMed Web of Science ®Google Scholar
• Cuzzolin L, Oggiano AM, Clemente MG, et al., Ceftriaxone-associated biliary pseudolithiasis in children: do we know enough? Fundam Clin Pharmacol. 2021;35(1): 40–52.
   PubMed Web of Science ®Google Scholar
• Christensen ML, Zareie P, Kadiyala B, et al. Concomitant ceftriaxone and intravenous calcium therapy in infants. J Pediatr Pharmacol Ther. 2021;26(7):702–707.
   PubMedGoogle Scholar
• Donnelly PC, Sutich RM, Easton R. Ceftriaxone-associated biliary and cardiopulmonary adverse events in neonates: a systematic review of the literature. Pediatr Drugs. 2017;19(1):21–34.
   PubMed Web of Science ®Google Scholar
• Ustyol L, Bulut MD, Agengin K, et al. Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: a prospective study in 154 children. Hum Exp Toxicol. 2017;36(6):547–553.
   PubMed Web of Science ®Google Scholar
• Biner B, Oner N, Celtik C, et al. Ceftriaxone-associated biliary pseudolithiasis in children. J Clin Ultra Sound. 2006;34(5):217–222.
   PubMed Web of Science ®Google Scholar
• Shaad UB, Tschaeppeler H, Lentze MJ. Transient formation of precipitations in the gallbladder associated with ceftriaxone therapy. Pediatr Infect Dis. 1986;5(6):708–710.
   PubMedGoogle Scholar
• Gulian JM, Gonard V, Dalmasso C, et al. Bilirubin displacement by ceftriaxone in neonates: evaluation by determination of “free” bilirubin and erythrocyte-bound bilirubin. J Antimicrob Chemother. 1987;19(6):823–829.
   PubMed Web of Science ®Google Scholar
• Martin E, Fanconi S, Kälin P, et al. Ceftriaxone-bilirubin-albumin interactions in the neonate: an in vivo study. Eur J Pediatr. 1993;152(6):530–534.
   PubMed Web of Science ®Google Scholar
• Van Reempts PJ, Van Overmeire B, Mahieu LM, et al. Clinical experience with ceftriaxone treatment in the neonate. Chemotherapy. 1995;41(4):316–322.
   PubMed Web of Science ®Google Scholar
• Wagner CL, Wagstaff P, Cox TH, et al. Early discharge with home antibiotic therapy in the treatment of neonatal infection. Am J Perinatol. 2000;20(6):346–350.
   Google Scholar
• NEJM Journal Watch [Internet]. Massachusetts: NEJM Group; 2009 [cited 2022 Mar 16]. Available from: https://www.jwatch.org/id200905060000001/2009/05/06/ceftriaxone-and-calcium-products
   Google Scholar
• Rocha AFB, Araújo MAL, Taylor MM, et al. Treatment administered to newborns with congenital syphilis during a penicillin shortage in 2015, Fortaleza, Brazil. BMC Pediatr. 2021;21(1):166.
   PubMed Web of Science ®Google Scholar
• Kafetzis DA, Brater DC, Kapiki AN, et al. Treatment of severe neonatal infections with cefotaxime. Efficacy and pharmacokinetics. J Pediatr. 1982;100(3):483–489.
   PubMed Web of Science ®Google Scholar
• Ellis JM, Rivera L, Reyes G, et al. Cefepime cerebrospinal fluid concentrations in neonatal bacterial meningitis. Ann Pharmacother. 2007;41(5):900–901.
   PubMed Web of Science ®Google Scholar
• Blumer JI, Aronoff SC, Myers CM, et al. Pharmacokinetics and cerebrospinal fluid penetration of ceftazidime in children with meningitis. Dev Pharmacol Ther. 1985;8(4):219.
   PubMedGoogle Scholar
• Steele RW, Eyre LB, Bradsher RW, et al. Pharmacokinetics of ceftriaxone in pediatric patients with meningitis. Antimicrob Agents Chemother. 1983;23(2):191–194.
   PubMed Web of Science ®Google Scholar
• Martin E, Koup JR, Paravicini U, et al. Pharmacokinetics of ceftriaxone in neonates and infants with meningitis. J Pediatr. 1984;105(3):475–481.
   PubMed Web of Science ®Google Scholar
• Bradley JS, Stone GG, Chan PLS, et al. Phase 2 study of the safety, pharmacokinetics and efficacy of ceftaroline fosamil in neonates and very young infants with late-onset sepsis. Pediatr Infect Dis J. 2020;39(5):411–418.
   PubMed Web of Science ®Google Scholar
• Stucki A, Acosta F, Cottagnoud M, et al. Efficacy of ceftaroline fosamil against Escherichia coli and Klebsiella pneumoniae strains in a rabbit meningitis model. Antimicrob Agents Chemother. 2013;57(12):5808–5810.
   PubMed Web of Science ®Google Scholar
• Chauzy A, Nadji A, Combes JC, et al. Cerebrospinal fluid pharmacokinetics of ceftaroline in neurosurgical patients with an external ventricular drain. J Antimicrob Chemother. 2019;74(3):675–681.
   PubMed Web of Science ®Google Scholar
• Cies JJ, Moore WS, Enache A, et al. Ceftaroline cerebrospinal fluid penetration in the treatment of a ventriculopleural shunt infection: a case report. J Pediatr Pharmacol Ther. 2020;25(4):336–339.
   PubMedGoogle Scholar
• Mermer S, Turhan T, Bolat E, et al. Ceftaroline versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in an experimental MRSA meningitis model. J Glob Antimicrob Resist. 2020;22:147–151.
   PubMed Web of Science ®Google Scholar
• Tsai MH, Chu SM, Hsu JF, et al. Risk factors and outcomes for multidrug-resistant Gram-negative bacteremia in the NICU. Pediatrics. 2014;133(2):e322–e329.
   PubMed Web of Science ®Google Scholar
• Hope WW, Castagnola E, Groll AH, et al. ESCMID Fungal Infection Study Group ESCMID guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect. 2012;18(7):38–52.
   PubMedGoogle Scholar
• Clark RH, Bloom BT, Spitzer AR, et al. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics. 2006;117(1):67–74.
   PubMed Web of Science ®Google Scholar
• Flannery DD, Puopolo KM, Hansen NI, et al. Antimicrobial susceptibility profiles among neonatal early-onset sepsis pathogens. Pediatr Infect Dis J. 2022;141(3):263–271.
   Google Scholar
• Lutsar I, Friedland IR. Pharmacokinetics and pharmacodynamics of cephalosporins in cerebrospinal fluid. Clin Pharmacokinet. 2000;39(5):335–343.
   PubMed Web of Science ®Google Scholar